Gas chromatography-ion mobility spectrometry for the detection of human disease: A review

Abstract

Gas chromatography-ion mobility spectrometry (GC-IMS) is an advanced technology for detecting trace compounds, due to its non-destructive, straightforward, and rapid analytical capabilities. However, the summary of GC-IMS in human disease is barely reported. This review summarizes the application and related parameters of GC-IMS in human disease diagnosis. GC-IMS detects volatile organic compounds in human breath, feces, urine, bile, etc. It can be applied to diagnose diseases, such as respiratory diseases, cancer, enteropathy, Alzheimer’s disease, bacterial infection, and metabolic diseases. Several potential disease markers have been identified by GC-IMS, including ethanal (COVID-19), 2-heptanone (lung cancer) and 3-pentanone (pulmonary cryptococcosis). In conclusion, GC-IMS offers a non-invasive approach to monitor and diagnose human diseases with broad applications.